[ Price : $8.95]
Mesoblast says it will refile its BLA for remestemcel-L for treating pediatric steroid-refractory acute graft versus host disease ...[ Price : $8.95]
FDA issues a warning to not use certain over-the-counter analgesic products that are marketed for topical use to relieve pain befo...[ Price : $8.95]
Federal Register notice: FDA announces that it is withdrawing approval of the indications for treating adult patients with advance...[ Price : $8.95]
CDER creates a new Center of Excellence for Quantitative Medicine to advance therapeutic medical product development and inform re...[ Price : $8.95]
FDA posts a notification about four information collections that have been approved by OMB.[ Price : $8.95]
Medline Industries recalls certain kits, trays and packs in direct response to Nurse Assists 11/2023 recall of 0.9% sodium chlorid...[ Price : $8.95]
FDA approves Johnson & Johnsons Opsynvi, a combination single tablet of macitentan and tadalafil for treating adults with pulmonar...[ Price : $8.95]
FDA sends Regeneron Pharmaceuticals two complete response letters on its BLA for odronextamab in relapsed/refractory follicular ly...